Reference
Lyu M, et al. The combined use of chemotherapy and radiotherapy with PD-1 inhibitor, pembrolizumab, in advanced cervical cancer: A case report. OncoTargets and Therapy 13: 4465-4471, 21 May 2020. Available from: URL: http://doi.org/10.2147/OTT.S245190
Rights and permissions
About this article
Cite this article
Carboplatin/paclitaxel/pembrolizumab. Reactions Weekly 1810, 65 (2020). https://doi.org/10.1007/s40278-020-80085-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80085-0